Tilray | TRLY - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Akebia Therapeutics 349.66M 12.86M 2026-06
Alaunos Therapeutics USD 1.07M 215K 2023-06
Aurora Cannabis CAD 230K 1.88M 2026-03
Avita Medical AUD 1.25M 100K 2025-06
Canopy Growth CAD 12.31M 4.97M 2026-03
Cronos Group USD 0 7K 2024-09
Dianthus Therapeutics USD 4.44M 263K 2024-09
Divis Laboratories Ltd INR 60M 0 2026-06
Ionis Pharmaceuticals USD 18M 1000K 2026-06
IQVIA Holdings USD 197M 5M 2026-06
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Moderna USD 10.96B 527M 2026-06
Organigram Holdings CAD 179K 127K 2025-03
Organon & Co USD 108M 3M 2026-06
Revvity USD 22.99M 1.73M 2026-06
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Tilray USD 6.7M 2.73M 2025-06
Viatris USD 120.7M 600K 2026-06
Xeris Pharmaceuticals USD 6.88M 269K 2026-03
Zealand Pharma A/S 7.07M 74K 2025-12